News from skyhawk therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

12 May, 2020, 13:00 BST Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced that it has expanded its strategic collaboration with Merck, known as MSD outside the United...


12 Nov, 2019, 14:00 GMT Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a second global strategic collaboration with an affiliate of Celgene...


04 Sep, 2019, 15:27 BST RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced Dr. Phillip Sharp has joined as special advisor to its Scientific Advisory Board. Dr. Sharp's ...


16 Jul, 2019, 13:00 BST Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a multi-target exclusive option and license agreement with Genentech, a ...


08 Jul, 2019, 12:30 BST Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced the expansion of its collaboration with Biogen, originally announced January 4, 2019. The...


08 Jul, 2019, 12:30 BST Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered a strategic collaboration with Merck, known as MSD outside the United States ...


08 Jul, 2019, 12:15 BST Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology

Skyhawk Therapeutics, Inc. ("Skyhawk") today announced that Dr. Tyler Jacks has joined the company as head of its Scientific Advisory Board, and Dr....


06 May, 2019, 14:27 BST Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration with Takeda Pharmaceutical Company Limited (Takeda) in which Skyhawk...


12 Feb, 2019, 18:31 GMT Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced Dr. Roberto Guerciolini has joined the company as its Chief Medical Officer. Dr. Guerciolini...


04 Jan, 2019, 12:31 GMT Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

Biogen Inc (Nasdaq: BIIB) and Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration in which the companies will leverage...


26 Jun, 2018, 12:31 BST Skyhawk Therapeutics Announces $40 Million Equity Investment Round

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced the closing of a new $40 million equity investment round alongside its recently announced $60 ...


26 Jun, 2018, 12:30 BST Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform

Skyhawk Therapeutics, Inc. ("Skyhawk"), today announced a global strategic collaboration with a Celgene Corporation affiliate ("Celgene") to...